Search

everythinglearnresearchcommunity

for

Search:↓

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Activated erbB-2 in mice skin causes severe skin and hair abnormalities.

COX2 and ATP synthase control the size of hedgehog spines.

PDCD4 is important for controlling skin cell growth and healing.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Syntaxin 9 helps in transporting and signaling of the EGF receptor in skin and stomach cells.

Betacellulin helps blood vessel growth in wounds but delays hair growth.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Localized breast cancer can affect skin and hair.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.